By the ZIVOLABS Medical Team · Updated April 2026 · 7 min read

One of the most common questions people ask before starting GLP-1 treatment is whether they have to take an injection — and whether there is a tablet they could take instead. The answer is yes, both forms exist. But they are not interchangeable, and understanding the difference matters before you decide.

The same molecule, two very different delivery systems

Both the injection and the oral tablet contain semaglutide — the same GLP-1 receptor agonist. The difference is entirely in how the drug gets into your bloodstream.

The injection (Ozempic, Semasize, Semanat) delivers semaglutide directly into the tissue beneath your skin — the subcutaneous layer in your abdomen, thigh, or upper arm. From there it is absorbed into the bloodstream steadily. Because it bypasses the digestive system entirely, almost all of the dose reaches circulation. It is taken once a week.

The oral tablet (Rybelsus, made by Novo Nordisk) contains the same semaglutide molecule but must survive the journey through your stomach — an environment that would normally destroy a peptide like semaglutide almost immediately. To make this possible, the tablet is combined with an absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl) aminocaprylate]), which protects the molecule and helps it absorb through the stomach lining. It is taken once daily.

How effective is each form?

This is where the two diverge meaningfully.

The absorption of oral semaglutide is inherently less efficient than injection. Even under ideal conditions, only around 1% of the oral dose reaches circulation — which is why the tablet doses (3 mg, 7 mg, 14 mg daily) are much higher than the injection doses (0.25 mg to 1 mg weekly) to achieve comparable blood levels.

In clinical trials:

• The 14 mg oral tablet (maximum approved dose) produced average weight loss of approximately 5–7% of body weight

• The 1 mg weekly injection produced average weight loss of approximately 10–15% of body weight

• The 2.4 mg weekly injection (Wegovy, not yet widely available in India) produced average weight loss of approximately 15–17% of body weight

The injection consistently outperforms the tablet for weight loss. For diabetes management, the oral tablet is effective — but for weight management, the injection is the clinical standard.

The oral tablet has strict requirements

The oral semaglutide tablet is not simply a tablet you take with your morning coffee. It has specific requirements that significantly affect whether it works:

• It must be taken on an empty stomach — nothing eaten or drunk for at least 30 minutes before and after

• It must be taken with no more than 120 ml (half a glass) of plain water — no tea, no juice, no milk

• Even a small amount of food or a larger volume of water dramatically reduces absorption

In practice, many patients find these requirements difficult to maintain consistently — particularly in Indian households where morning routines involve chai, coffee, or early breakfast. Missing the window even occasionally reduces the effectiveness of that day's dose.

The injection, by contrast, is taken once a week on any day at any time of day, with or without food.

Is oral semaglutide available in India?

As of 2026, Rybelsus (the oral semaglutide tablet) is available in India through some hospital pharmacies and specialty outlets, but it is not as widely accessible as the injection generics (Semasize, Semanat). It is also still under Novo Nordisk's brand and priced accordingly — considerably more expensive than generic injectable semaglutide.

There are currently no DCGI-approved generic oral semaglutide tablets from Indian manufacturers. The injectable generics are the accessible, affordable, and clinically superior option for weight management in India right now.

Who might prefer the oral tablet?

Despite the lower efficacy and stricter requirements, there are patients for whom the oral tablet may be the better starting point:

Severe needle anxiety. A small number of patients experience genuine phobia around injections that cannot be resolved with reassurance. For these patients, starting on oral semaglutide and transitioning to injection later — if appropriate — may be a more manageable path.

Diabetes management without weight focus. If the primary goal is blood sugar control rather than significant weight loss, the oral tablet can be effective and may suit patients who prefer not to inject.

Doctor's clinical judgment. In some cases a doctor may recommend starting with the oral formulation based on a patient's specific health picture.

For the majority of patients seeking weight management in India, the injectable form is what your doctor will recommend — and for good reason.

What about the injection — is it really as simple as it sounds?

Many people assume the injection will be difficult or painful. In practice, the pre-filled semaglutide pen is designed for self-administration by non-medical users.

The needle is very fine and short — most patients describe the sensation as a mild pinch at most, comparable to a mosquito bite. The injection sites (abdomen, upper thigh, outer upper arm) are areas with sufficient subcutaneous fat that the needle does not reach muscle.

The process takes less than 30 seconds. Your ZIVOLABS doctor will walk you through it during your consultation and written instructions are included with your delivery.

Summary: injection vs oral tablet at a glance

Frequently asked questions

Will the injection hurt? Most patients report it does not. The needle is very fine, the injection is subcutaneous (not into muscle), and the pre-filled pen is designed for ease of use. It becomes routine within a few weeks.

Can I switch from injection to tablet later? Yes, with your doctor's guidance. Some patients start on injection for faster results and ask about transitioning. Others do the reverse. Any switch should be discussed with your prescribing doctor.

Does the tablet work at all for weight loss? It does — but produces roughly half the weight loss of the injection on average. For patients who have significant weight to lose or who have comorbidities like PCOD, diabetes, or hypertension, the injection's stronger effect is clinically meaningful.

Want to discuss which form is right for you?

A ZIVOLABS doctor can review your profile and make a clear recommendation based on your goals, health history, and preferences.

[Start your free health assessment →]

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified doctor before starting any new treatment. Individual results may vary.